SEC Form 4 · accession 0001562180-19-000654
GENTEX CORP · GNTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James H Wallace
Director
Period of report
Jan 31, 2019
Accepted (ET)
Feb 1, 2019 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000355811
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2019 | M | 12,000 | $11.195 | A | 29,400 | D | |
| Common Stock | Jan 31, 2019 | M | 12,000 | $15.855 | A | 41,400 | D | |
| Common StockF1 | Jan 31, 2019 | S | 24,000 | $21.3961 | D | 17,400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-employee Director Stock Option (Right to buy) | $15.855 | Jan 31, 2019 | M | 12,000 | D | Nov 12, 2011 | May 12, 2021 | Common Stock | 12,000 | 0 | D |
| Non-employee Director Stock Option (Right to buy) | $11.195 | Jan 31, 2019 | M | 12,000 | D | Nov 17, 2012 | May 17, 2022 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $21.375 to $21.435. The price reported above reflects the weighted average price.